Webinars

Join us to discover how leveraging dynamic workflows to review, query, track, and collaborate cross-functionally in a clinical trial can result in better trial conduct, potential study amendments, and evolving clinical strategies.

In this interactive webinar, brought to you by IQVIA, we will explore the critical role for mutually beneficial partnership between the pharmaceutical industry and the NHS in helping to deliver better outcomes for patients, especially as critical efficiencies need to be identified in the wake of this global pandemic.

It's no secret that Phase 4 trials are incredibly time consuming, costly, and pose major challenges for sponsors and CROs alike. Whether it's Long Term Follow Up (LTFU), Rollover, and Observational studies, or Registry and Consumer Health studies, sponsors often struggle to recruit and retain large numbers of participants. They also have difficulties addressing post-marketing commitments to assess long term drug safety and efficacy.

Patient centric blood sampling is an approach for the collection of high quality samples for the determination of pharmacokinetic, pharmacodynamic and clinical chemistry endpoints. The technologies offer the potential to collect high quality samples from patients away from the centralized clinical settings, such as in the home, thus putting the needs of the patient at the center. This panel discussion will introduce attendees to the technologies available, and through the presentation of case studies, will explore the benefits and challenges of implementing these technologies for pediatric clinical trials. This will be followed by a lively debate including questions from the audience.

Join this session as a panel of experts discusses the realized benefits of using AI and communication tools to redefine the care pathway to detect stroke and streamline the patient journey to direct more patients for cardiology follow-up. They will share recent experience and data on how the latest innovations and platforms are improving the cryptogenic stroke care pathway.

NTT DATA and Snowflake will discuss how to navigate the challenges of newly available health plan pricing transparency data due to the CMS Transparency in Coverage ruling. Our data model powered by Snowflake provides a comprehensive solution that allows provider negotiation teams to use this data to their competitive advantage and ensures high value utilization through easy consumption. We will walk through the three most important components of this solution that enable users to compare negotiated rates down to the procedure code level across facilities with incorporated metrics. The session includes a live demo of the sample executive reports that can be produced per client basis followed by an informative discussion on Snowflake's strategy in the healthcare space.

In this free webinar, learn how to leverage real-world data and existing digital health data to develop and validate digital biomarkers. Attendees will learn what to look for in a digital biomarker and what it takes to validate one. The featured speakers will discuss key success factors in reusing existing digital health data and some of the regulatory and clinical decision-making considerations. Attendees will also learn how to manage patient privacy issues.

In this webinar, experienced revenue cycle operators will discuss the new report's findings, common issues related to payer adjudication and the gaps seen in revenue cycle processes that often lead to underpayments. Speakers will also provide an overview of effective resolution strategies that have been deployed across more than 200 hospitals nationwide to tackle these very problems.

Self-pay accounts are far more time-consuming and costly to collect on than those billed to commercial payers. Unfortunately, they're on the rise. To protect your margins in unpredictable financial times, it's crucial to find available coverage whenever and wherever you can.Â

In this webinar, representatives from different stakeholder groups (patients, physicians, health economists and industry) will discuss the value of increasing the use of non-OS endpoints in reimbursement decision-making to their stakeholder groups. Using the example of multiple myeloma, the speakers will discuss how and when non-OS endpoints should be used, to support a future in which assessments of novel therapies are more fit-for-purpose.Â

In this free webinar, learn about the importance of real-world evidence (RWE) as an end-to-end capability. Attendees will gain insights into meaningful ways to leverage RWE for business growth today and in the future. The featured speakers will discuss obstacles and roadblocks to future success and implementation.